← Leaderboards
Aria F Olumi
Massachusetts General Hospital
$5,702,955
Attributed
$5,958,497
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2011–25$2M$1.5M$1M$500K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,958,497 · 5
By mechanism
R01$5,948,497 · 4
R13$10,000 · 1
Top collaborators
- Zongwei Wang1 shared
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Robert J Handa$12,425,327
- Steven Kyle Grinspoon$75,757,679
- Katarina J Ruscic$197,080
Others in their field
Top investigators on “Prostate”
- David Heimbrook · Leidos Biomedical Research, Inc.$257,543,614
- Charles A Coltman · Southwest Oncology Group$181,133,593
- Leonard Freedman · Leidos Biomedical Research, Inc.$63,277,106
- Larry Arthur$62,719,328
- William J. Blot · Vanderbilt University$62,640,427
- Walter John Curran · Thomas Jefferson University$60,981,384
Research focus
ProstateEnzymesAdultResistanceOxidoreductaseBenign Prostatic HypertrophySecondary ToAndrogensMedicalLower Urinary Tract SymptomsGrowth And Development FunctionProstaticAffectObstructionBladderTissuesProteinsMethylationProtein ExpressionResistance MechanismAccountingEpithelial CellsMagnetic Resonance ImagingFinasteride
Grant awards (15)
New Treatment Strategies and Epigenetic Biomarker for Management of BPH$615,602
R01 · FY2025 · DK · contact PI
Decreased SRD5A2 and Alternative Estrogen Signaling in Prostatic Cell Survival$507,083
R01 · FY2025 · DK · contact PI
New Treatment Strategies and Epigenetic Biomarker for Management of BPH$598,609
R01 · FY2024 · DK · contact PI
Decreased SRD5A2 and Alternative Estrogen Signaling in Prostatic Cell Survival$511,084
R01 · FY2024 · DK
SRD5A2 as a Marker of Resistance to 5ARI Therapy$350,217
R01 · FY2024 · DK · contact PI
SRD5A2 as a Marker of Resistance to 5ARI Therapy$364,809
R01 · FY2023 · DK · contact PI
SRD5A2 as a Marker of Resistance to 5ARI Therapy$364,809
R01 · FY2022 · DK · contact PI
SRD5A2 as a Marker of Resistance to 5ARI Therapy$364,809
R01 · FY2021 · DK · contact PI
SRD5A2 as a Marker of Resistance to 5ARI Therapy$381,309
R01 · FY2020 · DK · contact PI
2019 AUA-SBUR BASIC SCIENCES SYMPOSIUM SOCIAL (AND ANTISOCIAL) CELL SIGNALING NETWORKS IN THE URINARY TRACT$10,000
R13 · FY2019 · DK · contact PI
Reduced Levels of 5-alpha Reductase 2 in Adult Prostate Tissue and BPH Therapy$380,625
R01 · FY2015 · DK · contact PI
Reduced Levels of 5-alpha Reductase 2 in Adult Prostate Tissue and BPH Therapy$380,625
R01 · FY2014 · DK · contact PI
Reduced Levels of 5-alpha Reductase 2 in Adult Prostate Tissue and BPH Therapy$367,304
R01 · FY2013 · DK · contact PI
Reduced Levels of 5-alpha Reductase 2 in Adult Prostate Tissue and BPH Therapy$380,625
R01 · FY2012 · DK · contact PI
Reduced Levels of 5-alpha Reductase 2 in Adult Prostate Tissue: Implications for$380,987
R01 · FY2011 · DK · contact PI